Aspirin inhibits the production of reactive oxygen species by downregulating Nox4 and inducible nitric oxide synthase in human endothelial cells exposed to oxidized low-density lipoprotein

Journal of Cardiovascular Pharmacology

Volumn 59, Issue 5, 2012, Pages 405-412

  Chen, Beidong ^a   Zhao, Jinjing ^a   Zhang, Shan ^a   Wu, Wei ^a   Qi, Ruomei ^a  

^a Beijing Key Laboratory of Geriatric Cognitive Disorders   (China)

Author keywords

aspirin; endothelial cells; iNOS; NF B; Nox4; ox LDL

Indexed keywords

ACETYLSALICYLIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSCRIPTION FACTOR RELA;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; DOWN REGULATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UMBILICAL VEIN ENDOTHELIAL CELL;

ASPIRIN; CHEMOKINE CCL2; DOWN-REGULATION; FIBRINOLYTIC AGENTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; NADPH OXIDASE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR RELA;

EID: 84861099119     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318248acba     Document Type: Article

References (33)

1. Armitage ME, Wingler K, Schmidt HH, et al. Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. J Mol Med (Berl). 2009;87:1071-1076.
2. Ceolotto G, Gallo A, Papparella I, et al. Rosiglitazone reduces glucoseinduced oxidative stress mediated by NAD (P) H oxidase via AMPKdependent mechanism. Arterioscler Thromb Vasc Biol. 2007;27:2627-2633.
3. Miller FJ Jr, Filali M, Huss GJ, et al. Cytokine activation of nuclear factor κB in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ Res. 2007;101:663-671.
4. Bedard K, Krause KH. The Nox family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87:245-313.
5. Roy Chowdhury SK, Sangle GV, Xie X, et al. Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells. Am J Physiol Endocrinol Metab. 2010;298:E89-E98.
6. Stielow C, Catar RA, Muller G, et al. Novel Nox inhibitor of oxLDLinduced reactive oxygen species formation in human endothelial cells. Biochem Biophys Res Commun. 2006;344:200-205.
7. 2+ currents via lysophosphatidylcholineinduced mitochondrial reactive oxygen species (ROS) production. Cardiovasc Res. 2006;69:855-864.
8. Steffen Y, Schewe T, Sies H. Epicatechin protects endothelial cells against oxidized LDL and maintains NO synthase. Biochem Biophys Res Commun. 2005;331:1277-1283.
9. Kilbourne EJ. Low-density lipoprotein inhibits receptor-mediated prostaglandin synthesis without affecting calcium and arachidonic acid mobilization in human endothelial cells. J Cardiovasc Pharmacol. 2004;44:607-614.
10. Kibbe M, Billiar T, Tzeng E. Inducible nitric oxide synthase and vascular injury. Cardiovasc Res. 1999;43:650-657.
11. Lee NP, Cheng CY. Nitric oxide and cyclic nucleotides: their roles in junction dynamics and spermatogenesis. Oxid Med Cell Longev. 2008;1:25-32.
12. Yu Z, Zhang W, Kone BC. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor κB. Biochem J. 2002;367(pt 1):97-105.
13. Zhao J, Qi R, Li R, et al. Protective effects of aspirin against oxidized LDL-induced inflammatory protein expression in human endothelial cells. J Cardiovasc Pharmacol. 2008;51:32-37.
14. Chung BH, Wilkinson T, Geer JC, et al. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res. 1980;21:284-291.
15. Fürst R, Brueckl C, Kuebler WM, et al. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD (P) H oxidase/Nox2-activation. Circ Res. 2005;96:43-53.
16. Kuroda T, Kitadai Y, Tanaka S, et al. Monocyte chemoattractant protein-1 transfection induces angiogenesis and tumorigenesis of gastric carcinoma in nude mice via macrophage recruitment. Clin Cancer Res. 2005;11:7629-7636.
17. Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993;90:11693-11697.
18. Niederberger E, Manderscheid C, Grösch S, et al. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells. Biochem Pharmacol. 2004;68:341-350.
19. Xu H, Goettsch C, Xia N, et al. Differential roles of PKCα and PKC∈ in controlling the gene expression of Nox4 in human endothelial cells. Free Radic Biol Med. 2008;44:1656-1667.
20. de Winther MP, Kanters E, Kraal G, et al. Nuclear factor κB signaling in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25:904-914.
21. Arima N, Kuziel WA, Grdina TA, et al. IL-2-induced signal transduction involves the activation of nuclear NF-κB expression. J Immunol. 1992;149:83-91.
22. Lavie J, Dandre F, Louis H, et al. Vascular cell adhesion molecule-1 gene expression during human smooth muscle cell differentiation is independent of NF-κB activation. J Biol Chem. 1999;274:2308-2314.
23. Zhang S, Chen B, Wu W, et al. Ginkgolide B reduces inflammatory protein expression in oxidized low-density lipoprotein-stimulated human vascular endothelial cells. J Cardiovasc Pharmcol. 2011;57:721-727.
24. Kumar SD, Yong SK, Dheen ST, et al. Cardiac malformations are associated with altered expression of vascular endothelial growth factor and endothelial nitric oxide synthase genes in embryos of diabetic mice. Exp Biol Med (Maywood). 2008;233:1421-1432.
25. Chen JW, Chen YH, Lin SJ. Long-term exposure to oxidized low-density lipoprotein enhances tumor necrosis factor-α-stimulated endothelial adhesiveness of monocytes by activating superoxide generation and redox-sensitive pathways. Free Radic Biol Med. 2006;40:817-826.
26. Krause KH. Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases. Exp Gerontol. 2007;42:256-262.
27. Wu R, Lamontagne D, de Champlain J. Antioxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation. 2002;105:387-392.
28. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424.
29. Persson K, Sauma L, Säfholm A, et al. LDL and UV-oxidized LDL induce upregulation of iNOS and NO in unstimulated J774 macrophages and HUVEC. APMIS. 2009;117:1-9.
30. Valenti L, Dongiovanni P, Motta BM, et al. Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler Thromb Vasc Biol. 2011;31:683-690.
31. Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000;101:2889-2895.
32. Serebruany V, Sani Y, Eisert C, et al. Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) biomarker substudy. Thromb Haemost. 2011;105:81-87.
33. Taubert D, Berkels R, Grosser N, et al. Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br J Pharmacol. 2004;143:159-165.